重药控股涨2.04%，成交额3.33亿元，主力资金净流出1446.46万元

Core Viewpoint - The stock of Chongqing Pharmaceutical Holdings has shown a significant increase in price this year, with a year-to-date rise of 21.68%, despite a recent decline in the last five trading days [1] Group 1: Stock Performance - As of December 26, the stock price reached 6.51 yuan per share, with a market capitalization of 11.25 billion yuan [1] - The stock has experienced a 4.82% decline over the last five trading days, but a 23.53% increase over the last 20 days and a 28.66% increase over the last 60 days [1] - The company has appeared on the trading leaderboard twice this year, with the most recent net purchase of 158 million yuan on December 15 [1] Group 2: Financial Performance - For the period from January to September 2025, the company reported a revenue of 62.21 billion yuan, reflecting a year-on-year growth of 4.22%, and a net profit attributable to shareholders of 384 million yuan, which is a 31.41% increase [2] - The company has distributed a total of 864 million yuan in dividends since its A-share listing, with 294 million yuan distributed in the last three years [3] Group 3: Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 4.05% to 42,000, while the average circulating shares per person increased by 4.22% to 41,112 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 10.09 million shares, an increase of 851,000 shares compared to the previous period [3]